“Institutional Cost Savings through Dose Banding Strategy of Pembrolizumab in Oncology Patients: A Real-World Data Analysis”. Universitas Scientiarum (November 4, 2025): S19. Accessed November 10, 2025. https://revistas.javeriana.edu.co/index.php/scientarium/article/view/41540.